Skip to main content
OpenTrials

Clinical trial condition

Purpura

Explore clinical trials studying Purpura. Study availability and eligibility vary by location and protocol.

378 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Purpura trial results

Completed

A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)

NCT03393975

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations
  • Winship Cancer Institute Atlanta, Georgia, United States
  • Alliance for Childhood Diseases, Cure 4 the Kids Foundation Las Vegas, Nevada, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View all 33 locations
View Trial Details
Completed

Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer

NCT06444477

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +19 more
Locations
  • AP-HP Hôpital Jean Verdier service de médecine interne Bondy, France
  • CHU de Clermont-Ferrand - service de médecine interne Clermont-Ferrand, France
  • AP-HP Hôpital Mondor service de médecine interne Créteil, France
  • AP-HP Hôpital Bicêtre service de médecine interne Le Kremlin-Bicêtre, France
View all 20 locations
View Trial Details
Completed

Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)

NCT06665308

Conditions
Adult Immune Thrombocytopenia, Autoimmune Diseases, Blood Coagulation Disorders, +18 more
Locations
  • USC Norris Comprehensive Cancer Center- Site Number : 8400002 Los Angeles, California, United States
  • Massachusetts General Hospital- Site Number : 8400001 Boston, Massachusetts, United States
  • University of Washington-Fred Hutchinson Cancer Center_Site Number: 8400003 Seattle, Washington, United States
  • Investigational Site Number: 8260001 London, London, City of, United Kingdom
View Trial Details
Completed

Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura

NCT05468320

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations
  • University of Alabama- Site Number : 8400011 Birmingham, Alabama, United States
  • Johns Hopkins University- Site Number : 8400007 Baltimore, Maryland, United States
  • Duke University Medical Center Site Number : 8400022 Durham, North Carolina, United States
  • The Ohio State University Comprehensive Cancer Center - Site Number : 8400001 Columbus, Ohio, United States
View all 27 locations
View Trial Details
Completed

A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

NCT04074187

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations
  • Investigational Site Number 3920009 Iruma-Gun, Japan
  • Investigational Site Number 3920014 Kanazawa, Japan
  • Investigational Site Number 3920007 Kashihara-shi, Japan
  • Investigational Site Number 3920013 Kawasaki-Shi, Japan
View Trial Details

Related conditions